Alcon Science Resource Library

Watch the case study for Results of Phase 3 Studies for Acoltremon Ophtalmic Solution 0.003%, a Novel TRPM8 Agonist.

Study Objectives and Assessments: Comet-1: Evaluate the safety and efficacy of two doses of topical ophthalmic AR-15512 compared with vehicle in subjects with DED (Phase 2b); Comet-2&3: Evaluate the safety and efficacy of…

Dry eye disease (DED) impacts approximately 30 million Americans and can have significant effects on their daily function and quality of life. Prescription drugs for DED in the United States predominately target reducing…

Watch this educational video to learn more about Dry Eye Disease. Affecting over 3 million Americans, Dry Eye significantly reduces comfort, vision, and quality of life. It stems from tear deficiency, triggering a cycle of…

Corneal Transient Receptor Potential (TRP) Ion Channels Respond to Environmental Stimuli

Christopher Lievens, and Andrew D. Pucker, OD, PhD, FAAO, FSLS, FBCLA, discuss a clinical trial that evaluated DAILIES TOTAL1 contact lenses in patients who had discontinued contact lens use due to discomfort or dryness. The…

This video shares insights from a multicenter, open-label study on Netarsudil ophthalmic solution, focusing on its effectiveness in lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. It…

Increased understanding of fluidics has contributed to the evolution of vitrectomy cutters; Flow for balanced saline solution (BSS) and vitreous behave differently due to material properties; Advancements in vitrectomy cutter…

Dry eye disease (DED) is a complex and highly prevalent ocular condition with unique challenges for eye care practitioners